BEIJING, Oct. 13, 2017 /PRNewswire/ -- China Biologic
Products Holding, Inc. (NASDAQ: CBPO) ("China Biologic" or the
"Company"), a leading fully integrated plasma-based
biopharmaceutical company in China, today announced that the Company will
host a conference call to
discuss the TianXinFu acquisition on Monday,
October 16, 2017 before market opens at 8:30 a.m. ET (8:30
p.m. Beijing Time). Listeners may access the call by
dialing:
|
US:
|
1 888 346
8982
|
|
International:
|
1 412 902
4272
|
|
Hong Kong:
|
800 905
945
|
|
China:
|
400 120
1203
|
A telephone replay will be available one hour after the
conclusion of the conference call through October 23, 2017. The dial-in details are:
|
US:
|
1 877 344
7529
|
|
International:
|
1 412 317
0088
|
|
Passcode:
|
10113508
|
A live and archived webcast of the conference call will be
available through the Company's investor relations website at
http://chinabiologic.investorroom.com/.
About China Biologic Products Holdings, Inc.
China Biologic Products Holdings, Inc. (NASDAQ: CBPO) is a
leading fully integrated plasma-based biopharmaceutical company in
China. The Company's products are
used as critical therapies during medical emergencies and for the
prevention and treatment of life-threatening diseases and
immune-deficiency related diseases. China Biologic is headquartered
in Beijing and manufactures over
20 different dosage forms of plasma products through its majority
owned subsidiary, Shandong Taibang Biological Products Co., Ltd.,
and its wholly owned subsidiary, Guizhou Taibang Biological
Products Co., Ltd. The Company also has an equity investment in
Xi'an Huitian Blood Products Co., Ltd. The Company sells its
products to hospitals, distributors and other healthcare facilities
in China. For additional
information, please see the Company's website
www.chinabiologic.com.
Contact:
China Biologic Products Holdings, Inc.
Mr. Ming Yin
Senior Vice President
Phone: +86-10-6598-3099
Email: ir@chinabiologic.com
ICR Inc.
Mr. Bill Zima
Phone: +86-10-6583-7511 or +1-646-405-5191
E-mail: william.zima@icrinc.com
View original
content:http://www.prnewswire.com/news-releases/china-biologic-products-announces-conference-call-to-discuss-tianxinfu-acquisition-300536335.html
SOURCE China Biologic Products Holdings, Inc.